Activation of latent lyme borreliosis concurrent with a herpes simplex virus type 1 infection

Scandinavian Journal of Infectious Diseases

Volumn 34, Issue 12, 2002, Pages 922-924

  Gylfe, Åsa ^a   Wahlgren, Mats ^b,c   Fahlén, Linda ^d   Bergström, Sven ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE;

ADULT; ARTICLE; BORRELIA AFZELII; CASE REPORT; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE DEFICIENCY; LYME DISEASE; RASH; STRESS; SUPERINFECTION; TICK BITE; TREATMENT OUTCOME;

ADULT; ANIMALS; BASE SEQUENCE; BORRELIA; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IXODES; LYME DISEASE;

EID: 0036995674     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/0036554021000026972     Document Type: Article

References (27)

1. Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 1999; 12: 633-53.
2. Gern L, Estrada-Pena A, Frandsen F, Gray JS, Jaenson TG, Jongejan F, et al. European reservoir hosts of Borrelia burgdorferi sensu lato. Zentralbl Bakteriol 1998; 287: 196-204.
3. Weber K, Burgdorfer W. Aspects of Lyme borreliosis. Berlin: Springer, 1993.
4. Stanek G, O'Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granströ M, et al. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996; 108: 741-7.
5. Mackowiak PA. Microbial latency. Rev Infect Dis 1984; 6: 649-68.
6. Apanius V. Stress and immune defense. In: Møller AP, Milinski M, Slater PJB, eds. Stress and behaviour, vol. 27. San Diego, CA: Academic Press, 1998: 133-53.
7. Padgett DA, Sheridan JF, Dorne J, Berntson GG, Candelora J, Glaser R. Social stress and the reactivation of latent herpes simplex virus type 1. Proc Natl Acad Sci USA 1998; 95: 7231-5.
8. Gylfe Å, Bergström S, Lundström J, Olsen B. Reactivation of Borrelia infection in birds. Nature 2000; 403: 724-5.
9. Jonsson M, Noppa L, Barbour AG, Bergström S. Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of osp operons of three isolates of different geographic origins. Infect Immun 1992; 60: 1845-53.
10. Bundoc VG, Barbour AG. Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi. Infect Immun 1989; 57: 2733-41.
11. Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, Burgdorfer W, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983; 308: 733-40.
12. Kryuchechnikov VN, Korenberg EI, Scherbakov SV, Kovalevsky Iu V, Levin ML. Identification of Borrelia isolated in the USSR from Ixodes persulcatus (Schulze) ticks. J Microbiol Epidemiol Immunobiol 1988; 41-44.
13. Bergström S, Olsen B, Burman N, Gothefors L, Jaenson TG, Jonsson M, Mejlon HA. Molecular characterization of Borrelia burgdorferi isolated from Ixodes ricinus in northern Sweden. Scand J Infect Dis 1992; 24: 181-8.
14. Åsbrink E, Hovmark A, Hederstedt B. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol 1984; 64: 506-12.
15. Shoberg RJ, Jonsson M, Sadziene A, Bergström S, Thomas DD. Identification of a highly cross-reactive outer surface protein B epitope among diverse geographic isolates of Borrelia spp. causing Lyme disease. J Clin Microbiol 1994; 32: 489-500.
16. Baranton G, Postic D, Saint Girons I, Boerlin P, Piffaretti JC, Assous M, Grimont PA. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992; 42: 378-83.
17. Barbour AG, Hayes SF, Heiland RA, Schrumpf ME, Tessier SL. A Borrelia-specific monoclonal antibody binds to a flagellar epitope. Infect Immun 1986; 52: 549-54.
18. Barbour AG, Tessier SL, Todd WJ. Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun 1983; 41: 795-804.
19. Comstock LE, Fikrig E, Shoberg RJ, Flavell RA, Thomas DD. A monoclonal antibody to OspA inhibits association of Borrelia burgdorferi with human endothelial cells. Infect Immun 1993; 61: 423-31.
20. Bunikis J, Olsen B, Fingerle V, Bonnedahl J, Wilske B, Bergstrom S. Molecular polymorphism of the Lyme disease agent Borrelia garinii in northern Europe is influenced by a novel enzootic Borrelia focus in the North Atlantic. J Clin Microbiol 1996; 34: 364-8.
21. Bunikis J, Noppa L, Bergström S. Molecular analysis of a 66-kDa protein associated with the outer membrane of Lyme disease Borrelia. FEMS Microbiol Lett 1995; 131: 139-45.
22. Moter SE, Hofmann H, Wallich R, Simon MM, Kramer MD. Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR. J Clin Microbiol 1994; 32: 2980-8.
23. Gylfe Å, Olsen B, Strasevicius D, Marti Ras N, Weihe P, Noppa L, et al. Isolation of Lyme disease Borrelia from puffins (Fratercula arctica) and seabird ticks (Ixodes uriae) on the Faeroe Islands. J Clin Microbiol 1999; 37: 890-6.
24. Robertson J, Guy E, Andrews N, Wilske B, Anda P, Granström M, et al. European multicenter study of immunoblotting in scrodiagnosis of Lyme borreliosis. J Clin Microbiol 2000; 38: 2097-102.
25. Magnarelli LA. Current status of laboratory diagnosis for Lyme disease. Am J Med 1995; 98: 10-2S.
26. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 1996; 34: 1-9.
27. Chang TW. Recurrent viral infection (reinfection). N Engl J Med 1971; 284: 765-73.